Dr. Jennifer M. Spangle is an Assistant Professor at the Department of Radiation Oncology, Emory University School of Medicine. Prior to joining Emory, she was an Instructor of Pathology at Dana-Farber Cancer Institute and Harvard Medical School. She graduated with honors from the University of Arizona with a BS in Molecular and Cellular Biology. She earned her PhD in Virology from Harvard Medical School in Boston, Massachusetts. She completed her postdoctoral training at Dana-Farber Cancer Institute and Harvard Medical School in Boston, Massachusetts, where she was the American Cancer Society Lee Denim Postdoctoral Fellow. Her research program hopes to utilize PI3K-mediated epigenetic rewiring to identify actionable targets and durable and efficacious combination therapies for the treatment of PI3K-activated cancers.
Dr. Jennifer M. Spangle is an Assistant Professor at the Department of Radiation Oncology, Emory University School of Medicine. Prior to joining Emory, she was an Instructor of Pathology at Dana-Farber Cancer Institute and Harvard Medical School. She graduated with honors from the University of Arizona with a BS in Molecular and Cellular Biology. She earned her PhD in Virology from Harvard Medical School in Boston, Massachusetts. She completed her postdoctoral training at Dana-Farber Cancer Institute and Harvard Medical School in Boston, Massachusetts, where she was the American Cancer Society Lee Denim Postdoctoral Fellow. Her research program hopes to utilize PI3K-mediated epigenetic rewiring to identify actionable targets and durable and efficacious combination therapies for the treatment of PI3K-activated cancers.